April 2023
Vol. 20 #4
The first episode of RegRapPod, our new Regulatory Rapporteur podcast series, is available to listen to now. Hosted by Managing Editor Alan Booth, our April Issue Editor Vickie Goff discusses the main focus topic of Latin America. We also hear from authors Priti Shah and Anna Litsiou who share some of the main insights from their article about the regulatory process of AstraZeneca’s COVID-19 vaccine.
Related articles
Industry newsHIV-prevention drug is first to be made in South Africa
Indian firm Cipla is first manufacturer approved to produce generic of the
HIV-preventer cabotegravir, in South Africa.- Industry news
WHO says COVID-19 ‘no longer a global health emergency’
SARS-Cov-2 – which caused the COVID-19 pandemic – “no longer a public health emergency of international concern”: WHO.
- Journal
Does sole dependence on reliance models contribute to a sustainable healthcare ecosystem?
Governments should strive for a sustainable and global regulatory framework adept to deal with a healthcare crisis and similar issues that may arise in the future. This article looks at regulatory frameworks in international regions through AstraZeneca’s experience with the VaxzevriaTM vaccine.
More Podcast
- Podcast
Conversations:
Regulating Vaxzevria:
The world’s first COVID-19 vaccineVol. 20 #4
MEMBER EXCLUSIVE:
Hosted by Alan Booth, managing editor of Regulatory Rapporteur, this episode of RegRapPod is an extended conversation with authors Priti Shah and Anna Litsiou following on from their article in the April issue [Vol. 20 #4]. Priti and Anna share insights around the regulatory process of AstraZeneca’s COVID-19 vaccine - Vaxzevria.
The Organisation for Professionals in Regulatory Affairs
- Issues
- Contact us
- Topics A-Z
- Contributors A-Z
- Copyright © 2023 The Organisation for Professionals in Regulatory Affairs Ltd. t/a Regulatory Rapporteur - All rights reserved
No comments yet